NOTV

Inotiv Inc

Add to Watchlist

Advanced Chart

1.580

-0.02(-1.250%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

1.690

Open

1.620

VWAP

1.62

Vol

422.65K

Mkt Cap

54.28M

Low

1.565

Amount

685.80K

EV/EBITDA(TTM)

28.10

Total Shares

25.97M

451.13M

EV/OCF(TTM)

P/S(TTM)

0.10

Inotiv, Inc. is a contract research company engaged in providing nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries and selling a range of research-quality animals and diets to the same industries, as well as academia and government clients. Its products and services focus on bringing new drugs and medical devices through the discovery and preclinical phases of development. It operates through two segments: Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through DSA segment, it supports the discovery, nonclinical development and clinical development needs of researchers and clinicians for primarily small molecule drug candidates, as well as biotherapeutics and biomedical devices. Through RMS segment, it offers access to a range of small and large research models for basic research and drug discovery and development, as well as specialized models for specific diseases and therapeutic areas.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q1

FY2025Q4

131.18M

+5.52%

-0.470

+6.82%

126.53M

+5.55%

-0.510

-50%

133.35M

+2.25%

-0.460

-36.99%

Estimates Revision

The market is revising Downward the revenue expectations for Inotiv, Inc. (NOTV) for FY2025, with the revenue forecasts being adjusted by -0.07% over the past three months. During the same period, the stock price has changed by -46.62%.

Revenue Estimates for FY2025

Revise Downward

-0.07%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+0.86%

In Past 3 Month

Stock Price

Go Down

-46.62%

In Past 3 Month

3 Analyst Rating

Wall Street analysts forecast NOTV stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for NOTV is 3.75 USD with a low forecast of 2.50 USD and a high forecast of 5.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

2 Buy

1 Hold

0 Sell

Moderate Buy

Current: 1.580

Low

2.50

Averages

3.75

High

5.00

Current: 1.580

Low

2.50

Averages

3.75

High

5.00

Lake Street

Frank Takkinen

Buy

downgrade

$6 -> $5

2025-05-08

Reason

Lake Street

Frank Takkinen

Price Target

$6 -> $5

2025-05-08

downgrade

Buy

Reason

Lake Street analyst Frank Takkinen lowered the firm's price target on Inotiv to $5 from $6 and keeps a Buy rating on the shares. Inotiv's recovery "continues to trend favorably," but the firm is taking a more conservative stance with its revenue and EBITDA estimates as it now believes its prior view of the recovery ramp was "too steep," the analyst tells investors.

Lake Street

Frank Takkinen

Hold

Strong Buy

Upgrades

$2 → $4

2024-09-30

Reason

Lake Street

Frank Takkinen

Price Target

$2 → $4

2024-09-30

Upgrades

Hold

Strong Buy

Reason

See All Ratings

Valuation Metrics

The current forward P/E ratio for Inotiv Inc (NOTV.O) is -0.85, compared to its 5-year average forward P/E of 2.11. For a more detailed relative valuation and DCF analysis to assess Inotiv Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

N/A

5Y Average PE

2.11

Current PE

-0.85

Overvalued PE

32.40

Undervalued PE

-28.18

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Fair

5Y Average EV/EBITDA

13.33

Current EV/EBITDA

10.05

Overvalued EV/EBITDA

21.33

Undervalued EV/EBITDA

5.33

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

N/A

5Y Average PS

0.72

Current PS

0.11

Overvalued PS

1.59

Undervalued PS

-0.14

Financials

Annual

Quarterly

FY2025Q3

YoY :

+23.54%

130.68M

Total Revenue

FY2025Q3

YoY :

-71.81%

-4.94M

Operating Profit

FY2025Q3

YoY :

-32.62%

-17.58M

Net Income after Tax

FY2025Q3

YoY :

-49.00%

-0.51

EPS - Diluted

FY2025Q3

YoY :

-40.43%

-11.45M

Free Cash Flow

FY2025Q3

YoY :

+131.91%

15.26

Gross Profit Margin - %

FY2025Q3

YoY :

+418.64%

-9.18

FCF Margin - %

FY2025Q3

YoY :

-45.46%

-13.45

Net Margin - %

FY2025Q3

N/A

ROIC

Trading Trends

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

7.4K

USD

3-6

Months

12.9K

USD

6-9

Months

436.4K

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

696.3K

USD

Months

Hedge Fund

Hedge Funds are Neutral. There are no significant trading trends over the last quarter.

Sold

0-3

Months

0.0

Volume

3-6

Months

0.0

Volume

6-9

Months

0.0

Volume

0-12

Months

0.0

Volume

Bought

0-3

0.0

Volume

Months

3-6

0.0

Volume

Months

6-9

0.0

Volume

Months

0-12

0.0

Volume

Months

Congress Trading

Congress are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

0.0

USD

3-6

Months

0.0

USD

6-9

Months

0.0

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

0.0

USD

Months

Insider

Insiders are Neutral. There are no significant trading trends over the last month.

Sold

0-3

Months

7.4K

USD

3-6

Months

12.9K

USD

6-9

Months

436.4K

USD

0-12

Months

0.0

USD

Bought

0-3

0.0

USD

Months

3-6

0.0

USD

Months

6-9

0.0

USD

Months

0-12

696.3K

USD

Months

NOTV News & Events

Events Timeline

2025-08-18 (ET)

2025-08-18

16:26:55

Inotiv reports a cybersecurity breach

2025-04-11 (ET)

2025-04-11

08:42:07

Lake Street doesn't expect Inotiv financial impact from FDA 'headline noise'

2025-04-10 (ET)

2025-04-10

16:02:42

Inotiv drops after FDA says phasing out animal testing of monoclonal antibodies

News

8.5

08-29SeekingAlpha

Inotiv submits $350M mixed securities registration statement

9.5

08-07Newsfilter

CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update

9.5

08-07Yahoo Finance

CORRECTING and REPLACING - Inotiv Reports Third Quarter Financial Results for Fiscal 2025 and Provides Business Update

People Also Watch

LFT

Lument Finance Trust Inc

SB Financial Group Inc

Champions Oncology Inc

TScan Therapeutics Inc

First Guaranty Bancshares Inc

FAQ

What is Inotiv Inc (NOTV) stock price today?

The current price of NOTV is 1.58 USD — it has decreased -1.25 % in the last trading day.

NOTV

Market Estimates

Valuation Metrics

Forward PE

Forward EV/EBITDA

Forward PS

Financials

Trading Trends

NOTV News & Events

Events Timeline

News

Inotiv's Recent Developments

People Also Watch

FAQ

What is Inotiv Inc (NOTV) stock price today?

What is Inotiv Inc (NOTV)'s business?

What is the price predicton of NOTV Stock?

What is Inotiv Inc (NOTV)'s revenue for the last quarter?

What is Inotiv Inc (NOTV)'s earnings per share (EPS) for the last quarter?

What changes have occurred in the market's expectations for Inotiv Inc (NOTV)'s fundamentals?

How many employees does Inotiv Inc (NOTV). have?

What is Inotiv Inc (NOTV) market cap?